PREVALENCE OF HEPATITIS B SURFACE ANTIGEN CARRIER STATE IN PATIENTS WITH LICHEN PLANUS–REPORT OF 200 CASES FROM LAHORE, PAKISTAN

Authors

  • Atiya Mahboob
  • Tahir Saeed Haroon
  • Zafar Iqbal
  • Munir Akhtar Saleemi
  • Asma Munir

Abstract

Background: To determine the prevalence of hepatitis B surface antigen carrier state in patientswith lichen planus. Methods: A quasi experimental cross sectional study was done at Departmentof Dermatology, Shaikh Zayed Federal Postgraduate Medical Institute, Lahore, Pakistan, fromApril 2003 to March 2005. Two hundred clinically diagnosed cases of LP and equal number ofpatients with other dermatoses not reportedly associated with hepatitis B virus (HBV) infection(control group) were collected from Skin Out Patient Department. They were screened forhepatitis B surface antigen (HBsAg) by Enzyme Linked Immunosorbent Assay (ELISA).Statistical analysis was done by using SPSS package version 11. Results: Out of 200 patients ofeach group, three patients with LP and seven patients from control group were positive forHBsAg. The test of significance for proportions revealed that there was no significant difference(p>0.1) between two groups. Conclusion: No association between HBsAg carrier state and LPwas found in our study.Key Words: Lichen Planus; Hepatitis B surface antigen.

References

Lowe N J, Cudworth AG, Woodrow JC. HLA antigen in

lichen plus. Br J Dermatol 1976;95:169–71.

Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T–

cell clones in lichen planus. Br J Dermatol 2000;142:449–56.

Kawamura E, Nakamura S, Sasaki M, Ohyama Y, Kadena T,

Kumamaru W, et al. Accumulation of oligoclonal T cells in

the infiltrating lymphocytes is oral lichen planus. J Oral

Patho Med 2003;32:282–9.

Kofoed ML, Wantzin GL. Familial lichen planus – more

frequent than previously suggested? J Am Acad Dermatol

;13:50–4.

Graells J, Notario J, Badia F. Lichen planus in monozygotic

twins. Clin Exp Dermatol 1998;23:299.

J Ayub Med Coll Abbottabad 2007;19(4)

Halery S, Feuerman EJ. Abnormal glucose tolerance

associated with lichen planus. Acta Derm Venereol (stockh)

;59:167–70.

Almeyda J, Levontine A. Lichenoid drug eruptions. Br J

Dermatol 1971;85:604-7.

Vallejo GMJ, Huerta G, Cerero R, Seoane JM. Anxiety and

depression as risk factors for oral lichen planus. Dermatology

;203:303-7.

Monk B. Lichen planus and the liver. J Am Acad Dermatol

;12:122–3.

Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri

NG, Gasbarrini G. HCV infection and extrahepatic

manifestations. Hepatogastroenterology 2003;50:1149-54.

Graham-Brown RAC, Sarkany I, Sherlock S. Lichen planus and

primary biliary cirrhosis. Br J Dermatol 1982;106:699-703.

Cottoni F, Solinas A, Piga MR, Tocco A, Lissia M, Cerimele D

et al. Lichen planus, chronic liver disease and immunologic

involvement. Arch Dermatol Res 1988;208:555-60.

Ayala F, Balato N, Tranfaglia, Guadagnino V, Orlando R. Oral

erosive lichen planus and chronic liver disease. J Am Acad

Dermatol 1986;14:139-40.

Dogan B. Dermatological manifestations in hepatitis B surface

antigen carriers in east region of Turkey. J Eur Acad Dermatol

Venereol 2005;19:323-5.

Daramola OO,George AO, Ogunbiyi AO, Otegbayo JA.

Hepatitis B virus in Nigerians with lichen planus. West Afr J

Med 2004;23:104-6.

Denli YG, Durdu M, Karaksa M. Diabetes and hepatitis

frequency in 140 lichen planus cases in Cukurova region. J

Dermatol 2004;31:293-8.

Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Derarosi F

et al. Lichen palnus and hepatitis C virus: a multicenter study of

patients with oral lesions and a systemic review. Br J Dermatol

;151:1172-81.

Mahboob A, Haroon TS, Iqbal Z, Iqbal F, Butt AK. Frequency

of anti HCV antibodies in patients with lichen planus. J Coll

Physician Surg Pak 2003;1:248-51.

Kurokawa M, Hidaka T, Sasaki H, Nishikata I, Morishita K,

Setoyama M. Analysis of hepatitis C virus (HCV) RNA in the

lesions of lichen planus with chronic hepatitis C: detection of

antigenomic as well as genomic strand HCV RNAs in lichen

planus lesions. J Dermatol Sci 2003;32:65-70.

Assad T, Samdani AJ. Association of lichen palnus with

hepatitis C virus infection. Ann Saudi Med 2005;25:243–6.

Podanyi B, Lengyel G, Kiss A, Szakonyi J, Schaff Z, Feher J.

Association of chronic hepatitis C infection and lichen

planus. Orv Hetil 2006;147:547-50.

Kane M. Global programme for control of hepatitis B

infection. Vaccine 1995;13:547-9.

Andre F. Hepatitis B epidemiology in Asia, the Middle East

and Africa. Vaccine 2000;18:S20-2.

Ali N, Khattak J, Anwar M, Tariq WZ, Nadeem M et al.

Prevalence of hepatitis B surface antigen and hepatitis C

antibodies in young healthy adult. Pakistan J Pathol

;13:3-6.

Khattak MF, Salamat N, Bhatti FA, Qureshi TZ.

Seroprevalence of hepatitis B, C and HIV in northern

Pakistan. J Pak Med Assoc 2002;52:398-402.

Khokhar N, Gill ML, Malik GJ. General seroprevalence of

hepatitis B and hepatitis C virus infection in population. J

Coll phys Surg Pak 2004;12:534-6.

Chaudhary IA, Khan SA, Samiullah. Should we do hepatitis

B and C screening on each patient before surgery. Analysis

of 142 cases. Pak J Med Sci 2005:21:278-80.

Shah SMA, Khan MT, Zahour ullah, Ashfaq NY. Prevalence

of hepatitis B and Hepatitis C virus infection in

multitransfused thalassaemia major patients in northwest

frontier province. Pak J Med Sci 2005;21:281-4.

Shazi L, Abbas Z. Comparison of risk factors for hepatitis B

and C patients visiting a Gastroenterology clinic. JCPSP

;16:104-7.

Krugman S, Overby LR, Mushahwar IK, Ling CM, Frösner

GG, Deinhardt F. Viral hepatitis, type B. Studies on natural

history and prevention re-examined. N Engl J Med

;300:101-6.

Rinker J. Galambos JT. Prospective study of hepatitis B in

thirty-two nadvertently infected people. Gastroenterology

;9:97-115.

McElgunn Patrick SJ. Dermatologic manifestations of hepatitis

B virus infection. J Am Acad Dermatol 1983;8:539-48.

Kirtsching G, Wakelin SH, Wojnarowska F. Mucosal vulval

lichen planus: outcome, clinical and laboratory features. J

Eur Acad Dermatol Venereol 2005;19:301-7.

Bokor-Bratic M. Lack of evidence of hepatic disease in patients

with oral lichen planus in Serbia. Oral Dis 2004;10:283-6.

Míco-Llorens JM, Delgado-Molina E, Baliellas-Comellas C,

Berini-Aytés L, Gay-Escoda C. Association between B

and/or C chronic viral hepatitis and oral lichen planus. Med

Oral 2004;9:183-90.

Cooper SM, Kirtschig G, Jeffery KJ, Wojnarowska F. No

association between hepatitis B or C viruses and vulval

lichen planus in a UK population. BJOG 2004;111:271-3.

Ciaccio M, Rebora A. Lichen planus following HBV

vaccination: A coincidence? Br. J Dermatol 1990;22:424.

Limas C, Limas CJ. Lichen planus in children: a possible

complication of hepatitis B vaccines. Pediatr Dermatol

;19:204-9.

Agrawal A, Shenoi SD. Lichen planus secondary to hepatitis B

vaccination. Indian J. Dermatol venereal leprol 2004;70:234-5.

Calista D, Morri M. Lichen planus induced by hepatitis B

vaccination: a new case and review of the literature. Int J

Dermatol 2004;43:562-4.

Downloads

Most read articles by the same author(s)